Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Ellagic Acid.
Ellagic acid is a polyphenolic antioxidant that exerts potent chemopreventive and anti-inflammatory effects by modulating the NF-κB pathway and inhibiting oxidative stress-induced DNA damage.
5281855
302.19 g/mol
1.1
6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Ellagic Acid across standard consumer modalities.
Ellagic acid exhibits poor aqueous solubility and low bioavailability, requiring micronization or complexation to ensure consistent absorption in dry powder formats.
The high polyphenolic content can cause significant astringency and potential cross-linking with pectin matrices, which may negatively impact the final texture and flavor profile.
The relatively high therapeutic dose required for ellagic acid typically exceeds the 20-30mg payload capacity of thin-film oral strips, limiting its application in this format.
Ready to launch a product featuring Ellagic Acid? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Ellagic Acid extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Ellagic Acid payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation